share_log

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023

Benzinga ·  09/27/2023 23:00

UpgradesFor Telos Corp (NASDAQ:TLS), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the second quarter, Telos showed an EPS of $0.03, compared to $0.04 from the year-ago quarter. The current stock performance of Telos shows a 52-week-high of $11.23 and a 52-week-low of $1.53. Moreover, at the end of the last trading period, the closing price was at $1.94. According to Maxim Group, the prior rating for Cyclo Therapeutics Inc (NASDAQ:CYTH) was changed from Hold to Buy. Cyclo Therapeutics earned $0.33 in the second quarter, compared to $0.41 in the year-ago quarter. At the moment, the

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment